Arcturus Therapeutics (ARCT) Stock Insights

ARCT price $12.07 +0.84 +7.48%

Ticker
ARCT
Price
$12.07
Change
+0.84 +7.48%
Market cap ?
$343.07M
P/E ?
-3.37
Forward P/E ?
3.84
Dividend yield ?
0.00%
Beta ?
2.48
Sector
Healthcare
Industry
Biotechnology
Stocklytics score
48
Value
60
Quality
34
Growth
50

Stocklytics score rationale: value 60, quality 34, growth 50.

Financials

2016201720182019202020212022202320242025
2038200012998000157530002078900095390001235900020575500015774800013838900067221000

Arcturus Therapeutics Holdings Inc. is a biotechnology company focused on RNA-based medicines, developing a pipeline of vaccines for infectious diseases alongside treatments for rare liver and respiratory conditions across the United States. Its notable development programs encompass LUNAR-OTC, designed for ornithine transcarbamylase (OTC) deficiency, and LUNAR-CF, targeting cystic fibrosis lung disease caused by…

Fair value

ARCT fair value $68.29. Price $12.07. Price is 82% below fair value.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Calculated with a 10-year free-cash-flow discount. Starting free cash flow 18.97M. Growth 0.00%. When analyst earnings forecasts are available, free cash flow in those years is forecast earnings times the company's usual conversion of earnings into free cash flow, kept between 60% and 130%. Years with fewer than 3 analyst estimates are left out. Growth then fades in a straight line to terminal growth by year 10, starting from the last well-covered year's growth, or from the pace across those years when the final year slows sharply, kept between 0% and 20%. Without those forecasts, year-1 growth is analyst revenue growth for the next full fiscal year, or 5-year historical revenue growth when that forecast is missing, held for five years, then fading in a straight line to terminal growth by year 10. Terminal growth 3.00%. Discount rate 12.00% (beta 2.0). Beta is kept between 0.8 and 2.0, which on its own would make the discount rate 8.7% to 15.3%. The rate is then capped at 12%. A cap is used because a discount above 12% pushes higher-beta stocks further from the price. The discount rate stays at least 5 percentage points above terminal growth. Shares 28.42M. Net debt -205.91M. The earnings value is next-12-months earnings per share, or trailing earnings when that forecast is missing, times the median P/E of the company's industry. That median uses listed stocks worth at least $10 billion with a positive P/E of 100 or below, and the industry needs at least eight of them. Otherwise the sector median is used when that group also has at least eight, then the market median of those large companies. The multiple used is the lower of that median and 1.25 times the stock's own 10-year median P/E, then kept between 8 and 30. If the stock has no 10-year median, the peer median is kept between 8 and 30. Fair value is the average of the cash-flow value and the earnings value when both exist. Card and credit companies use the earnings value only, because changes in customer receivables distort free cash flow. Model uncertainty is high when fair value is more than 60% from the price, or when most of the cash-flow value sits after year 10.

Model uncertainty high for this stock

Compare ARCT

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-11-05—-0.60—8.04M
2026-08-06-0.84-1.002.96M3.11M
2026-05-07-0.95-1.032.06M6.30M
2026-03-03-1.03-0.927.20M15.90M
2025-11-10-0.49-0.8017.15M16.03M
2025-08-11-0.34-0.8928.30M18.83M
2025-05-12-0.52-1.5829.38M23.35M
2025-03-06-1.11-0.3322.77M39.95M
2024-11-07-0.26-0.7038.81M45.92M
2024-08-05-0.64-1.8545.98M34.25M
2024-05-08-1.00-1.1732.60M17.54M
2024-03-07-0.32-1.6928.21M37.86M
2023-11-14-0.61-1.7943.38M41.64M
2023-08-07-1.980.099.56M48.50M
2023-05-091.870.0680.28M37.94M
2023-03-284.430.98160.05M72.68M
2022-11-09-1.33-2.0113.37M4.57M
2022-08-09-0.82-1.8427.09M3.14M
2022-05-09-1.94-1.295.24M7.08M
2022-02-28-1.47-1.775.79M14.75M
2021-11-08-2.05-1.402.44M11.65M
2021-08-09-2.07-1.992.00M2.00M
2021-05-10-2.15-1.162.13M1.47M
2021-03-01-1.25-0.902.24M—
2020-11-09-0.92-0.472.33M1.59M
2020-08-10-0.55-0.532.32M2.32M
2020-05-07-0.67-0.492.65M2.41M
2020-03-11-0.76-0.492.97M2.07M
2019-11-07-0.56-0.243.32M2.13M
2019-08-15-0.07-0.5310.15M91.38M
2019-05-13-0.68-0.444.35M3.71M
2019-03-18-0.08-0.487.58M26.10M
2018-11-07-0.42-0.353.42M4.56M
2018-10-01-0.50-0.342.39M2.42M
2018-05-14-1.08-0.4613.00M2.04M
2018-04-02-0.66—2.37M—
2017-11-09-0.70-2.663.30M—
2017-08-11-0.91-0.943.76M—
2017-05-30-0.91-1.263.84M—
2017-02-15-1.54-1.90——

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency Special.

Safety score 43/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. Dividend history is short. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
2013-01-08$0.062013-01-082013-01-15Special
2013-01-04$0.062013-01-082013-01-15Monthly
2012-12-05$0.06—2012-12-15Monthly
2012-11-06$0.06—2012-11-15Monthly
2012-10-03$0.06—2012-10-15Monthly
2012-09-05$0.06—2012-09-15Monthly
2012-08-06$0.06—2012-08-15Monthly
2012-07-03$0.06—2012-07-15Monthly
2012-06-06$0.06—2012-06-15Monthly
2012-05-04$0.06—2012-05-15Monthly
2012-04-03$0.06—2012-04-15Monthly
2012-03-06$0.02—2012-03-15Monthly

Insider trades

DateInsiderActionSharesPriceValue
2026-06-05HOLMES EDWARD WBuy15.00K$7.30109.50K
2026-06-05FARRELL PETER CBuy15.00K$7.30109.50K
2026-06-05BARLOW JAMES FBuy15.00K$7.30109.50K
2026-06-05Markels JohnBuy15.00K$7.30109.50K
2026-06-05Slaoui MoncefBuy15.00K$7.30109.50K
2026-06-05Marquet MagdaBuy15.00K$7.30109.50K
2026-06-05Marantz Jing L.Buy15.00K$7.30109.50K
2026-05-01MULROY DENNISBuy100.00K$8.63863.00K
2026-05-01MULROY DENNISOther0——
2025-12-17Roberts JosephBuy10.00K$6.5265.20K
2025-12-17Chivukula PadBuy54.00K$6.52352.08K
2025-12-17Payne Joseph EBuy175.00K$6.521.14M
2025-12-17Kurata LanceBuy54.00K$6.52352.08K
2025-12-12Roberts JosephOther0——
2025-12-12Roberts JosephOther0——
2025-12-12Roberts JosephOther1.00K$37.4437.44K
2025-12-12Roberts JosephOther5.00K$14.1270.60K
2025-12-12Roberts JosephOther5.00K$8.0040.00K
2025-12-12Roberts JosephOther6.49K$99.29644.59K
2025-12-12Roberts JosephOther7.00K$34.57241.99K
2025-12-12Roberts JosephOther7.00K$16.92118.44K
2025-12-12Roberts JosephOther9.00K$16.24146.16K
2025-12-12Roberts JosephOther7.50K$28.88216.60K
2025-08-15SASSINE ANDYBuy1.24K$16.5620.50K
2025-08-15SASSINE ANDYSell1.24K$16.5620.50K
2025-06-09FARRELL PETER CBuy15.00K$12.54188.10K
2025-06-09Slaoui MoncefBuy15.00K$12.54188.10K
2025-06-09Marquet MagdaBuy15.00K$12.54188.10K
2025-06-09Markels JohnBuy15.00K$12.54188.10K
2025-06-09Marantz Jing L.Buy15.00K$12.54188.10K
2025-06-09BARLOW JAMES FBuy15.00K$12.54188.10K
2025-06-09HOLMES EDWARD WBuy15.00K$12.54188.10K
2024-12-16Kurata LanceBuy60.00K$16.24974.40K
2024-12-16Payne Joseph EBuy196.00K$16.243.18M
2024-12-16Chivukula PadBuy60.00K$16.24974.40K
2024-12-16SASSINE ANDYBuy60.00K$16.24974.40K
2024-10-15Chivukula PadSell12.00K$20.76249.12K
2024-06-19Slaoui MoncefBuy15.00K$25.96389.40K
2024-06-19Slaoui MoncefBuy14.79K$25.96384.05K
2024-06-19Slaoui MoncefOther0——
2024-06-14Marantz Jing L.Buy15.00K$31.00465.00K
2024-06-14Marantz Jing L.Buy3.13K——
2024-06-14Marantz Jing L.Sell3.13K——
2024-06-14HOLMES EDWARD WBuy15.00K$31.00465.00K
2024-06-14HOLMES EDWARD WBuy3.13K——
2024-06-14HOLMES EDWARD WSell3.13K——
2024-06-14Markels JohnBuy15.00K$31.00465.00K
2024-06-14Markels JohnBuy3.13K——
2024-06-14Markels JohnSell3.13K——
2024-06-14Marquet MagdaBuy15.00K$31.00465.00K
2024-06-14Marquet MagdaBuy3.13K——
2024-06-14Marquet MagdaSell3.13K——
2024-06-14BARLOW JAMES FBuy15.00K$31.00465.00K
2024-06-14BARLOW JAMES FBuy3.13K——
2024-06-14BARLOW JAMES FSell3.13K——
2024-06-14FARRELL PETER CBuy3.13K——
2024-06-14FARRELL PETER CBuy15.00K$31.00465.00K
2024-06-14FARRELL PETER CSell3.13K——
2024-06-12SASSINE ANDYSell50.00K$32.031.60M
2024-06-05Chivukula PadSell114$45.005.13K
2024-06-03Chivukula PadSell26.00K$40.011.04M
2024-03-25Chivukula PadSell17.43K$35.02610.57K
2024-03-19Chivukula PadSell8.56K$35.01299.84K
2023-12-15SASSINE ANDYBuy75.00K$28.882.17M
2023-12-15Chivukula PadBuy125.00K$28.883.61M
2023-12-15Kurata LanceBuy75.00K$28.882.17M
2023-12-15Kummerfeld Keith CBuy30.00K$28.88866.40K
2023-12-15Payne Joseph EBuy200.00K$28.885.78M
2023-11-01Chivukula PadSell5.00K$18.7293.60K
2023-10-02Chivukula PadSell5.00K$25.61128.06K
2023-09-01Chivukula PadSell5.00K$31.45157.26K
2023-08-15SASSINE ANDYBuy1.22K$17.3721.25K
2023-08-01Chivukula PadSell5.00K$34.91174.55K
2023-08-01Markels JohnBuy11.87K$34.92414.47K
2023-08-01Markels JohnBuy3.13K——
2023-08-01FARRELL PETER CBuy11.87K$34.92414.47K
2023-08-01FARRELL PETER CBuy3.13K——
2023-08-01Marantz Jing L.Buy11.87K$34.92414.47K
2023-08-01Marantz Jing L.Buy3.13K——
2023-08-01HOLMES EDWARD WBuy11.87K$34.92414.47K
2023-08-01HOLMES EDWARD WBuy3.13K——
2023-08-01BARLOW JAMES FBuy11.87K$34.92414.47K
2023-08-01BARLOW JAMES FBuy3.13K——
2023-08-01Marquet MagdaBuy11.87K$34.92414.47K
2023-08-01Marquet MagdaBuy3.13K——
2023-07-14Chivukula PadSell25.00K$35.01875.25K
2023-07-14Kummerfeld Keith CSell4.50K$9.0440.68K
2023-07-14Kummerfeld Keith CSell1.03K$14.1214.56K
2023-07-14Kummerfeld Keith CBuy1.03K$14.1214.56K
2023-07-14Kummerfeld Keith CSell1.44K$4.997.17K
2023-07-14Kummerfeld Keith CBuy1.44K$4.997.17K
2023-07-14Kummerfeld Keith CBuy4.50K$9.0440.68K
2023-07-14Kummerfeld Keith CSell6.97K$35.00243.88K
2023-07-03Chivukula PadSell5.00K$28.75143.75K
2023-06-01Chivukula PadSell5.00K$27.16135.80K
2023-05-11Chivukula PadSell7.92K$30.24239.65K
2023-05-10Chivukula PadSell17.07K$30.00512.25K
2023-05-01Chivukula PadSell5.00K$25.93129.65K
2023-04-18Kummerfeld Keith CBuy1.44K$4.997.17K
2023-04-18Kummerfeld Keith CBuy4.50K$9.0440.68K

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 140, holders +10 vs prior quarter. Ownership 88.72%.

HolderSharesChangeChange %Value
FEDERATED HERMES, INC.3.30M00.00%22.20M
ARK INVESTMENT MANAGEMENT LLC2.90M132.12K+4.77%19.50M
BLACKROCK, INC.2.61M731+0.03%17.57M
SUMITOMO MITSUI TRUST GROUP, INC.1.96M-325.81K-14.23%13.19M
AMOVA ASSET MANAGEMENT AMERICAS, INC.1.96M-328.48K-14.35%13.14M
VANGUARD CAPITAL MANAGEMENT LLC1.11M7.94K+0.72%7.49M
TWO SIGMA INVESTMENTS, LP1.09M9.35K+0.86%7.33M
VANGUARD PORTFOLIO MANAGEMENT LLC951.58K-26.35K-2.69%6.39M
GEODE CAPITAL MANAGEMENT, LLC693.66K32.73K+4.95%4.66M
AQR CAPITAL MANAGEMENT LLC675.01K513.74K+318.54%4.54M
JACOBS LEVY EQUITY MANAGEMENT, INC647.51K448.78K+225.83%4.35M
STATE STREET CORP569.60K25.73K+4.73%3.83M
UBS GROUP AG490.63K32.35K+7.06%3.30M
D. E. SHAW & CO., INC.392.36K140.32K+55.68%2.64M
EMPIRE LIFE INVESTMENTS INC.366.22K-17.28K-4.50%2.46M
HENNION & WALSH ASSET MANAGEMENT, INC.346.21K66.53K+23.79%2.33M
MILLENNIUM MANAGEMENT LLC337.00K-141.56K-29.58%2.26M
GOLDMAN SACHS GROUP INC309.86K111.18K+55.96%2.08M
BNP PARIBAS FINANCIAL MARKETS261.79K66.93K+34.35%1.76M
CHARLES SCHWAB INVESTMENT MANAGEMENT INC231.63K15.13K+6.99%1.56M
SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P.231.63K231.63KNew1.56M
POINT72 ASSET MANAGEMENT, L.P.231.58K167.74K+262.73%1.56M
DIMENSIONAL FUND ADVISORS LP221.32K-67.03K-23.25%1.49M
HEARTLAND ADVISORS INC219.30K-36.70K-14.34%1.47M
NORTHERN TRUST CORP204.58K-15.04K-6.85%1.37M

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

Arcturus Therapeutics (ARCT) Stock Insights

ARCT$12.07+0.84 +7.48%

$343.07M

Market Cap

-3.37

P/E

3.84

Forward P/E

48

Score

Price History